Format
Sort by
Items per page

Send to

Choose Destination

Best matches for VANCOMYCIN/AE:

Vancomycin-Induced Thrombocytopenia: A Narrative Review. Mohammadi M et al. Drug Saf. (2017)

Vancomycin toxicity in neonates: a review of the evidence. Lestner JM et al. Curr Opin Infect Dis. (2016)

Vancomycin-Associated Cast Nephropathy. Luque Y et al. J Am Soc Nephrol. (2017)

Search results

Items: 1 to 20 of 1332

1.

Red man syndrome following the use of vancomycin-loaded bone cement in the primary total knee replacement: A case report.

Chen CT, Ng KJ, Lin Y, Kao MC.

Medicine (Baltimore). 2018 Dec;97(51):e13371. doi: 10.1097/MD.0000000000013371.

2.

Vancomycin-induced severe thrombocytopenia in a young infant.

Chen QY, Wan J, Yang JH, Lin M, Chen Y.

Rev Soc Bras Med Trop. 2018 Nov-Dec;51(6):873-875. doi: 10.1590/0037-8682-0150-2018.

3.

Parenterally administered vancomycin in 29 dogs and 7 cats (2003-2017).

DeStefano IM, Wayne AS, Rozanski EA, Babyak JM.

J Vet Intern Med. 2019 Jan;33(1):200-207. doi: 10.1111/jvim.15357. Epub 2018 Nov 30.

4.

Vancomycin-loaded chitosan aerogel particles for chronic wound applications.

López-Iglesias C, Barros J, Ardao I, Monteiro FJ, Alvarez-Lorenzo C, Gómez-Amoza JL, García-González CA.

Carbohydr Polym. 2019 Jan 15;204:223-231. doi: 10.1016/j.carbpol.2018.10.012. Epub 2018 Oct 9.

PMID:
30366534
5.

Postoperative Hemorrhagic Occlusive Retinal Vasculitis with Intracameral Vancomycin.

Lee JY, Lee EK, Lee HJ, Jeong J, Lee SY, Kim JY.

Korean J Ophthalmol. 2018 Oct;32(5):430-431. doi: 10.3341/kjo.2018.0043. No abstract available.

6.

Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin.

Chamorro-Pareja N, Patel A, Youngberg G, Gonzalez-Estrada A.

BMJ Case Rep. 2018 Oct 8;2018. pii: bcr-2018-227378. doi: 10.1136/bcr-2018-227378. No abstract available.

PMID:
30301733
7.

Agranulocytosis Induced by Vancomycin. Case Report and Literature Review.

di Fonzo H, Villegas Gutsch M, Castroagudin A, Cabrera MV, Mazzei ME, Rueda D.

Am J Case Rep. 2018 Sep 3;19:1053-1056. doi: 10.12659/AJCR.909956. Review.

8.

Vancomycin-induced red man syndrome presentation in a preterm infant.

Martini S, Alessandroni R, Arcuri S, Faldella G.

Pediatr Dermatol. 2018 Nov;35(6):e408-e409. doi: 10.1111/pde.13654. Epub 2018 Aug 31.

PMID:
30168173
9.

Documented vancomycin-induced severe immune-mediated thrombocytopaenia.

Gerstein W, Colombo E, Harji F.

BMJ Case Rep. 2018 Aug 27;2018. pii: bcr-2018-224682. doi: 10.1136/bcr-2018-224682.

PMID:
30150336
10.

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis.

Castellazzi ML, Esposito S, Claut LE, Daccò V, Colombo C.

Ital J Pediatr. 2018 Aug 15;44(1):93. doi: 10.1186/s13052-018-0535-4.

11.
12.

Firvanq--vancomycin oral solution.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 16;60(1551):122. No abstract available.

PMID:
30036349
13.

Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney.

Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Mahamadu A, Dortbudak MB.

Biomed Pharmacother. 2018 Sep;105:981-991. doi: 10.1016/j.biopha.2018.06.048. Epub 2018 Jun 19.

PMID:
30021393
14.

Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosing.

Nakashima T, Koido K, Baba H, Otsuka R, Okinaka K, Sano T, Nishigaki R, Hashimoto H, Otsuka T, Esaki M, Terakado H.

Pharmazie. 2018 Jul 1;73(7):422-424. doi: 10.1691/ph.2018.8427.

PMID:
30001779
15.

Antibacterial gold nanoparticle-based photothermal killing of vancomycin-resistant bacteria.

Wang SG, Chen YC, Chen YC.

Nanomedicine (Lond). 2018 Jun;13(12):1405-1416. doi: 10.2217/nnm-2017-0380. Epub 2018 Jul 4.

PMID:
29972649
16.

Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.

Mikamo H, Tateda K, Yanagihara K, Kusachi S, Takesue Y, Miki T, Oizumi Y, Gamo K, Hashimoto A, Toyoshima J, Kato K.

J Infect Chemother. 2018 Sep;24(9):744-752. doi: 10.1016/j.jiac.2018.05.010. Epub 2018 Jun 19.

17.

Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant.

Prohaska L, Mahmoudjafari Z, Shune L, Singh A, Lin T, Abhyankar S, Ganguly S, Grauer D, McGuirk J, Clough L.

Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):233-240. doi: 10.1016/j.hemonc.2018.05.001. Epub 2018 Jun 18.

18.

Layer-by-layer nanocoating of antibacterial niosome on orthopedic implant.

Dwivedi A, Mazumder A, Nasongkla N.

Int J Pharm. 2018 Aug 25;547(1-2):235-243. doi: 10.1016/j.ijpharm.2018.05.075. Epub 2018 Jun 1.

PMID:
29864515
19.

Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections.

Shibata Y, Yamagishi Y, Mikamo H, Kato H, Nishiyama N, Asai N, Koizumi Y, Matsuura K, Suematsu H, Hagihara M.

J Infect Chemother. 2018 Sep;24(9):695-701. doi: 10.1016/j.jiac.2018.04.006. Epub 2018 May 25.

PMID:
29807867
20.

Drug-induced linear IgA bullous dermatosis in a patient with a vancomycin-impregnated cement spacer.

Riemenschneider K, Diiorio DA, Zic JA, Livingood MR, Fine JD, Powers JG, Zwerner JP, Tkaczyk E.

Cutis. 2018 Apr;101(4):293-296.

PMID:
29763476

Supplemental Content

Loading ...
Support Center